• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Anacor Pharmaceuticals, Inc. (ANAC)

    -NasdaqGM
    43.50 Down 0.60(1.36%) Feb 27, 4:00PM EST
    |After Hours : 43.50 Down 0.00 (0.01%) Feb 27, 4:38PM EST
    Add to Portfolio
    Prev Close:44.10
    Open:43.99
    Bid:N/A
    Ask:49.50 x 400
    1y Target Est:43.00
    Beta:1.71
    Earnings Date:Mar 11 - Mar 16 (Est.)
    Day's Range:42.88 - 44.03
    52wk Range:13.19 - 44.64
    Volume:420,453
    Avg Vol (3m):474,203
    Market Cap:1.87B
    P/E (ttm):34.77
    EPS (ttm):1.25
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ANAC

    Comparison

    Symbol% ChgMkt Cap
    ANACDown 1.36%1.87B
    JNJDown 0.28%285.03B
    NVSDown 0.58%245.62B
    SNYDown 0.02%128.58B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):96.87
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-2.40
    Quarterly EPS Est (Dec-14) :-0.61
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):1.17

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Anacor Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback